OpenAlex
PricingAboutJobs
Log inGet started
Work

A comparative safety review between GLP-1 receptor agonists and SGLT2 inhibitors for diabetes treatment

HTML

Year: 2018
Type: article
Source: Expert Opinion on Drug Safety
DOI: 10.1080/14740338.2018.1428305
Authors: Agostino Consoli, Gloria Formoso, Maria Pompea Antonia Baldassarre, Fabrizio Febo
Institution: University of Chieti-Pescara
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: GLP-1 receptor agonists, SGLT2 inhibitors, type 2 diabetes, drug safety, adverse events, exenatide, dulaglutide, liraglutide, semaglutide, lixisenatide, empagliflozin, dapagliflozin, canagliflozin, renal protection, cardiovascular risk, comparative safety
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2782780315
FWCI: 4.193
Cites: 94
Cited by: 44
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security